Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) EBT Margin Growth (5y) (2017 - 2026)

Analysis

Iqvia Holdings (IQV) EBT Margin Growth (5y) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.00
Mar 31, 2026 36.00
Dec 31, 2025 642.00
Sep 30, 2025 629.00
Jun 30, 2025 903.00
Mar 31, 2025 473.00
Dec 31, 2024 1,043.00
Sep 30, 2024 647.00
Jun 30, 2024 858.00
Mar 31, 2024 504.00
Dec 31, 2023 577.00
Sep 30, 2023 738.00
Jun 30, 2023 663.00
Mar 31, 2023 660.00
Dec 31, 2022 605.00
Sep 30, 2022 662.00
Jun 30, 2022 722.00
Mar 31, 2022 583.00
Dec 31, 2021 1,070.00
Sep 30, 2021 -454.00